Esophageal Squamous Cell Carcinoma — Trials

Esophageal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

555 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 212
Recruiting: 119
Ph III recruiting: 20
Growth YoY: +61.4%
Industry share: 23%
Top sponsor: Fudan University
Termination share: 25%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (35)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07769866	Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC	not yet recruiting	N/A	68	RenJi HospitalOTHER	1	Aug 18, 2026	clinicaltrials
NCT07067450	Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma	not yet recruiting	N/A	98	Sichuan UniversityOTHER	0	Jul 16, 2025	clinicaltrials
NCT05420480